BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aegerion Pharmaceuticals, Inc. 

101 Main Street
Suite 1850
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-500-7867 Fax: 908-541-1155


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 10/9/2014 7:31:25 AM
Aegerion Pharmaceuticals, Inc. (AEGR)Announces Presentation At The Leerink Rare Disease Roundtable 9/25/2014 7:41:13 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Observes Familial Hypercholesterolemia Awareness Day 9/24/2014 7:51:34 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 9/9/2014 7:49:35 AM
Aegerion Pharmaceuticals, Inc. (AEGR) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014 8:47:48 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Resolution Of Warning Letter For JUXTAPID® (Lomitapide) Capsules 8/27/2014 7:50:40 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Prices $300 Million Convertible Senior Notes Offering 8/12/2014 7:36:16 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Intention To Offer $250 Million Of Convertible Notes 8/11/2014 7:27:13 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 8/8/2014 7:56:25 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Appoints Craig Fraser As Chief Operating Officer 7/30/2014 10:33:39 AM
12345678910...